We are live on ! Find out more
DMK

David M. Knott Portfolio holdings

AUM $275M
1-Year Est. Return 59.23%
This Fund
S&P 500
This Quarter Est. Return
+17.38%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
AUM
$251M
AUM Growth
+$38.1M
Cap. Flow
+$12.8M
Cap. Flow %
5.09%
Top 10 Hldgs %
56.09%
Holding
115
New
14
Increased
19
Reduced
11
Closed
5

Sector Composition

Rank Sector Weight
1 Healthcare 31.16%
2 Industrials 13.21%
3 Technology 12.96%
4 Financials 9.05%
5 Communication Services 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INDP icon
26
Indaptus Therapeutics
INDP
$337M
$2.13M 0.85%
130
+3
+2% +$52.6K
BDSI
27
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$2.12M 0.85%
400,500
-99,800
-20% -$456K
STML
28
DELISTED
Stemline Therapeutics, Inc.
STML
$2.03M 0.81%
157,795
+2,000
+1% +$22.6K
DD icon
29
DuPont de Nemours
DD
$18.3B
$2.01M 0.8%
14,865
EIGR
30
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$1.84M 0.73%
4,378
XENE icon
31
Xenon Pharmaceuticals
XENE
$6.6B
$1.82M 0.73%
179,390
+6,000
+3% +$50.9K
ARNA
32
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1.64M 0.66%
36,676
-3,152
-8% -$145K
RDUS
33
DELISTED
Radius Health, Inc.
RDUS
$1.54M 0.61%
77,269
QTNT
34
DELISTED
Quotient Limited Ordinary Shares
QTNT
$1.53M 0.61%
4,250
+75
+2% +$26.4K
BRSL
35
Brightstar Lottery PLC
BRSL
$1.97B
$1.49M 0.6%
+115,000
New +$1.77M
AB icon
36
AllianceBernstein
AB
$3.54B
$1.46M 0.58%
50,500
CXW icon
37
CoreCivic
CXW
$3.03B
$1.46M 0.58%
75,000
ZGNX
38
DELISTED
Zogenix, Inc.
ZGNX
$1.43M 0.57%
26,039
FOMX
39
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$1.3M 0.52%
346,346
+140,146
+68% +$525K
HZNP
40
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.26M 0.5%
47,840
-25,800
-35% -$611K
AIMT
41
DELISTED
Aimmune Therapeutics
AIMT
$1.23M 0.49%
55,056
+2,199
+4% +$51.8K
VZ icon
42
Verizon
VZ
$182B
$1.08M 0.43%
18,311
RHP icon
43
Ryman Hospitality Properties
RHP
$7.99B
$1.02M 0.41%
12,400
JNJ icon
44
Johnson & Johnson
JNJ
$609B
$1.02M 0.41%
7,280
CNCE
45
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$1.01M 0.4%
83,607
+3,307
+4% +$48.7K
XRN.PRA
46
Chiron Real Estate Inc Series A Preferred Stock
XRN.PRA
$75.3M
$893K 0.36%
35,000
CNQ icon
47
Canadian Natural Resources
CNQ
$91.5B
$890K 0.35%
66,059
XLRN
48
DELISTED
Acceleron Pharma
XLRN
$810K 0.32%
17,400
MDLZ icon
49
Mondelez International
MDLZ
$78.3B
$794K 0.32%
15,900
EPRT icon
50
Essential Properties Realty Trust
EPRT
$7.21B
$781K 0.31%
40,000

Similar funds

David M. Knott's Q1 2019 Portfolio in Review

As of Q1 2019, David M. Knott held 115 positions worth $251M, up 18% from $213M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

David M. Knott deployed $12.8M of net new capital in Q1 2019, opening 14 new positions and adding to 19 existing holdings. Its largest new stake was Stericycle Inc: 224,083 shares worth $12.2M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 39% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Pfizer, an estimated $9.23M trimmed.

  • David M. Knott's largest Q1 2019 buy was Stericycle Inc: 224,083 shares worth $12.2M.
  • David M. Knott added most to The Stars Group Inc. in Q1 2019, an estimated $3.94M increase.
  • David M. Knott's biggest Q1 2019 reduction was Pfizer, cutting an estimated $9.23M.
  • David M. Knott fully exited Noble Energy, Inc. in Q1 2019, selling an estimated $1.8M.
  • David M. Knott's ten largest holdings make up 56% of its $251M portfolio in Q1 2019.
  • David M. Knott opened 14 new positions and closed 5 in Q1 2019.
  • David M. Knott's portfolio value rose 18% quarter-over-quarter to $251M.

Based on David M. Knott's 13F filing for Q1 2019, filed 13 May 2019.